Literature DB >> 20789115

ANNOTATIONS.

.   

Abstract

Year:  1961        PMID: 20789115      PMCID: PMC1953202     

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  10 in total

1.  Significance of selected central mechanisms for the analysis of the action of reserpine.

Authors:  H J BEIN
Journal:  Ann N Y Acad Sci       Date:  1955-04-15       Impact factor: 5.691

2.  Preganglionic sympathetic activity in normal and in reserpine-treated cats.

Authors:  A IGGO; M VOGT
Journal:  J Physiol       Date:  1960-01       Impact factor: 5.182

3.  Intraphepatic bile stasis in acute nonfatal viral hepatitis; its incidence, pathogenesis, and correlation with jaundice.

Authors:  I N DUBIN
Journal:  Gastroenterology       Date:  1959-05       Impact factor: 22.682

4.  Acute fatty metamorphosis of the liver in pregnancy. Report of a case complicating toxemia in pregnancy.

Authors:  A A NARDONE; P E STROUP; R J GILL
Journal:  Am J Obstet Gynecol       Date:  1960-08       Impact factor: 8.661

5.  The action of reserpine on the excretion of adrenaline and noradrenaline.

Authors:  J H GADDUM; W A KRIVOY; G LAVERTY
Journal:  J Neurochem       Date:  1958       Impact factor: 5.372

6.  Noradrenaline in artery walls and its dispersal by reserpine.

Authors:  J H BURN; M J RAND
Journal:  Br Med J       Date:  1958-04-19

7.  Brain reserpine levels following large and small doses of reserpine-H3.

Authors:  H SHEPPARD; W H TSIEN; A J PLUMMER; E A PEETS; B J GILETTI; A R SCHULERT
Journal:  Proc Soc Exp Biol Med       Date:  1958-04

8.  Changes of heart rate caused by direct cardiac action of reserpine.

Authors:  O KRAYER; J FUENTES
Journal:  J Pharmacol Exp Ther       Date:  1958-06       Impact factor: 4.030

9.  Edema and congestive failure related to administration of Rauwolfia serpentina.

Authors:  G A PERERA
Journal:  J Am Med Assoc       Date:  1955-10-01

10.  Pharmacological consequences of the selective release of peripheral norepinephrine by syrosingopine (Su 3118).

Authors:  F B ORLANS; K F FINGER; B B BRODIE
Journal:  J Pharmacol Exp Ther       Date:  1960-02       Impact factor: 4.030

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.